AI Summary & Key Takeaways
AI InsightWith appropriate and timely treatment approaches, the quality of life of these patients can be improved.
📌 3 Key Takeaways
Özet
Introduction: This study was a retrospective evaluation of the clinical and demographic features, as well as the congenital and acquired diseases of patients with Down syndrome (DS) followed up at the clinic. Methods: The hospital admission records and files of patients diagnosed with DS before the age of 18 were reviewed retrospectively. The age, gender, drugs used, and clinical diagnoses of the patients were recorded and statistical analysis was performed. Results: The data of a total of 214 DS patients who were admitted to the pediatric clinic between January 2014 and January 2017 were analyzed. In all, 96 (44.9%) patients were female and 118 (55.1%) were male. The mean age of the total group was 6.01±3.97 years. The mean age of the boys was 6.15±3.96 years, and it was 5.83±4.01 years for the girls. There was a significant difference in immunodeficiency between genders: 73.3% (n=33) of the 45 patients who were found to be immunodeficient were male (p=0.006). When the distribution of cases was analyzed according to concomitant diagnoses and age group, it was observed that 42.1% (n=24) of the 57 patients who were diagnosed with hypothyroidism were between 6 and 10 years of age (p=0.00), 52.1% (n=25) of the 48 patients who were diagnosed with epilepsy were between 6 and 10 years of age (p=0.00), all of the 13 patients who were diagnosed with anemia were between 0 and 5 years of age (p=0.009), 68.9% (n=31) of the 45 patients who were diagnosed as immunodeficient were between 0 and 5 years of age (p=0.019), and 90.6% (n=29) of the 32 patients who were diagnosed with hearing loss were between 0 and 5 years of age (p=0.00). There was a statistically significant difference in the age group of 0 to 5 years of age. Discussion and Conclusion: Periodic follow-up of children with DS should be performed in terms of additional diseases. With appropriate and timely treatment approaches, the quality of life of these patients can be improved.